Publications by authors named "D Tomek"

Claim this Profile
U
Utility of procalcitonin in a medical intensive care unit in Croatia.
Ana Vujaklija Brajković, Iva Košuta, Dora Tomek, Mia Rora, Jakša Babel

Wien Klin Wochenschr· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications.
Brian Godman, Andrew Hill, Steven Simoens, Gisbert Selke, Iva Selke Krulichová, Dominik Tomek

Expert Rev Pharmacoecon Outcomes Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Patient Access Barriers for Tumor Necrosis Factor Alpha Inhibitor Treatments in Rheumatoid Arthritis in Five Central Eastern European Countries.
András Inotai, Dominik Tomek, Maciej Niewada, László Lorenzovici, Martin Kolek

Front Pharmacol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA.
Patricia Vella Bonanno, Anna Bucsics, Steven Simoens, Antony P Martin, Wija Oortwijn, Dominik Tomek

Expert Rev Pharmacoecon Outcomes Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets.
Brian Godman, Anna Bucsics, Patricia Vella Bonanno, Wija Oortwijn, Celia C Rothe, Dominik Tomek

Front Public Health· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis